| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000030485 |
| Receipt No. | R000034751 |
| Scientific Title | Evaluation of efficacy and risks of vaccination for liver transplant recipients |
| Date of disclosure of the study information | 2018/12/20 |
| Last modified on | 2019/12/22 (Ver. 3) |
| Basic information | ||
| Public title | Evaluation of efficacy and risks of vaccination for liver transplant recipients | |
| Acronym | Vaccination for liver transplant recipients | |
| Scientific Title | Evaluation of efficacy and risks of vaccination for liver transplant recipients | |
| Scientific Title:Acronym | Vaccination for liver transplant recipients | |
| Region |
|
|
| Condition | ||
| Condition | Liver transplant recipients | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Efficacy and risks of vaccination for liver transplant recipients with
immunosuppressant |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Obtain immunity from vaccination 12 months after vaccination (IgG)
|
| Key secondary outcomes | Side effects of vaccination within 12months after vaccination |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Vaccination for patients with
immunosuppressant measles rubella mumps varicella each 1 time |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | More than 2 years after transplantation
Without steroid administration More than 1 year with stable liver functional tests |
|||
| Key exclusion criteria | Without inclusion criteria
With active infection |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine
Kyoto University |
||||||
| Division name | Division of Hepato-Biliary-Pancreatic surgery | ||||||
| Zip code | 606-8507 | ||||||
| Address | 54 Kawaracho Shogoin Sakyo-ku Kyoto, JAPAN | ||||||
| TEL | 075-751-3243 | ||||||
| ho1962@kuhp.kyoto-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine Kyoto University | ||||||
| Division name | Division of Hepato-Biliary-Pancreatic surgery | ||||||
| Zip code | 606-8507 | ||||||
| Address | 54 Kawaracho Shogoin Sakyo-ku Kyoto, JAPAN | ||||||
| TEL | 075-751-3243 | ||||||
| Homepage URL | |||||||
| ho1962@kuhp.kyoto-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kyoto University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyoto Unoversity |
| Address | Kawaharacho-54 Shogoin Sakyo-ku Kyoto, JAPAN |
| Tel | 075-751-3243 |
| ho1962@kuhp.kyoto-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034751 |